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ABSTRACT: CP12 is an 8.5-kDa nuclear-encoded chloroplast protein, isolated from higher plants. It forms
part of a core complex of two dimers of phosphoribulokinase (PRK), two tetramers of glyceraldehyde
3-phosphate dehydrogenase (GAPDH), and CP12. The role of CP12 in this complex assembly has not
been determined. To address this question, we cloned a cDNA encoding the mature CP12 from the green
alga Chlamydomonas reinhardtii and expressed it in Escherichia coli. Sequence alignments show that it
is very similar to other CP12s, with four conserved cysteine residues forming two disulfide bridges in the
oxidized CP12. On the basis of reconstitution assays and surface plasmon resonance binding studies, we
show that oxidized, but not reduced, CP12 acts as a linker in the assembly of the complex, and we propose
a model in which CP12 associates with GAPDH, causing its conformation to change. This GAPDH/
CP12 complex binds PRK to form a half-complex (one unit). This unit probably dimerizes due partially
to interactions between the enzymes of each unit. Reduced CP12 being unable to reconstitute the complex,
we studied the structures of oxidized and reduced CP12 by NMR and circular dichroism to determine
whether reduction induced structural transitions. Oxidized CP12 is mainly composed of R helix and coil
segments, and is extremely flexible, while reduced CP12 is mainly unstructured. Remarkably, CP12 has
similar physicochemical properties to those of “intrinsically unstructured proteins” that are also involved
in regulating macromolecular complexes, or in their assembly. CP12s are thus one of the few protein
families of intrinsically unstructured proteins specific to plants.
In recent years, the use of very sensitive analytical
techniques has revealed the presence of small proteins in
macromolecular complexes. Their presence raises questions
about their role in the formation and regulation of higher
order structures (1-3).
CP12 is a small, 8.5-kDa nuclear-encoded chloroplast
protein that has been isolated and cloned from a few
eukaryotic and prokaryotic photosynthetic organisms (4-
6). Many expressed sequence tags (ESTs) encoding putative
CP12 proteins have been found in a wide variety of
photosynthetic organisms in the past few years (7, 8). CP12
has been isolated as part of a core complex composed of
CP12, phosphoribulokinase (PRK), and glyceraldehyde
3-phosphate dehydrogenase (GAPDH).1 These enzymes are
regulated by light and are involved in CO2 assimilation in
photosynthetic organisms (Benson-Calvin cycle). Interest-
ingly, CP12 shares sequence homologies with the C-terminal
extension of GapB, a GAPDH subunit in the chloroplasts of
higher plants (4). This C-terminal end is responsible for the
oligomerization of the higher plant GAPDH (A2B2) into a
hexadecamer (A8B8), which is regulated by metabolites such
as 1,3-biphosphoglyceric acid (9, 10). In green algae,
GAPDH is present as an A4 homotetramer which has not
been shown to oligomerize to form a regulatory GAPDH.
Our group isolated a PRK/GAPDH complex, composed
of two dimers of PRK and two homotetramers A4 of
GAPDH, from the green alga Chlamydomonas reinhardtii
(11). Recent cryo-electron microscopy studies suggested that
other components are part of this complex (12). As Wedel
et al (5) have shown that CP12 occurs with GAPDH and
PRK in C. reinhardtii, this small protein was a good
candidate. Recent mass spectrometry and kinetic studies on
native GAPDH (isolated from the green alga) showed that
it was a complex of GAPDH and CP12 (13), confirming
that the complex described earlier by Avilan et al (11) was
the same as the one isolated by Wedel et al (5). The activities
of the enzymes involved in this complex are regulated in
vitro by metabolites such as NADP(H) (5, 6, 14) and
thioredoxins or the nonphysiological reducing agent DTT
(15).
A partial sequence of CP12 in C. reinhardtii was obtained
by PCR (5) (accession number in TrEMBL: 065775), but
the 5′ and 3′ ends corresponding to the N- and C-terminal
parts of the mature protein were missing. We have therefore
cloned the entire cDNA of algal CP12 and developed an
expression system in Escherichia coli.
* To whom correspondence should be addressed. Tel: 33 1 44 27
47 41. Fax: 33 1 44 27 57 16. E-mail: meunier@ijm.jussieu.fr.
‡ CNRS Universite´s Paris VI -VII.
§ CEA-CNRS.
| Botanisches Institut der Christian-Albrechts-Universita¨t zu Kiel.
1 Abbreviations: GAPDH: glyceraldehyde 3-phosphate dehydro-
genase, PRK: phosphoribulokinase, CD: circular dichroism, NMR:
nuclear magnetic resonance, SPR: surface plasmon resonance; IUP:
intrinsically unstructured protein.
8163Biochemistry 2003, 42, 8163-8170
10.1021/bi034474x CCC: $25.00 © 2003 American Chemical Society
Published on Web 06/17/2003
Previous studies on recombinant GAPDH (devoid of
CP12) and native GAPDH (associated with CP12) demon-
strated that the association of CP12 with GAPDH was
responsible for changes in the kinetic parameters of GAPDH,
probably due to conformation changes. These results already
defined a new function for CP12, different from the
regulatory one described earlier (5, 6). Nevertheless, since
the highly homologous C-terminal extension of gapB is
involved in the oligomerization of higher plant GAPDH, and
given that CP12 is also part of the PRK/CP12/GAPDH
complex, it may also play a role in the assembly of the
complex. We have therefore studied its role under oxidized
and reduced state in the assembly of the PRK/CP12/GAPDH
complex from C. reinhardtii. We used surface plasmon
resonance binding experiments to determine how this
complex might be assembled and for the first time, we
propose a model for its assembly pathway.
Since oxidized and reduced CP12 do not have the same
behavior regarding complex formation, and since no struc-
tural data were available for any of the cloned CP12 proteins,
we analyzed the structure of oxidized and reduced CP12 in
solution by NMR spectroscopy and circular dichroism (CD).
We also linked these results with the role of CP12 in the
assembly of the PRK/CP12/GAPDH complex.
EXPERIMENTAL PROCEDURES
cDNA Library Construction. C. reinhardtii (cw15) was
grown photoautotrophically for 4 days under a 16/8 h light/
dark regime in high salt medium (16) with 5% CO2 in the
air during the light phase. The exponentially growing cells
were then harvested 2.5 (A) and 6 h (B) after light setting.
Nucleic acids were isolated by three rounds of phenol/
chloroform and a final chloroform extraction. The total
nucleic acids were precipitated with potassium acetate/2-
propanol and separated by LiCl precipitation. The polyade-
nylated RNA was purified by chromatography on oligo-dT
cellulose (Pharmacia, Freiburg) and cDNA was synthesized
using a Pharmacia (Freiburg) kit. Double-stranded adapter-
linked cDNAs were ligated into the dephosphorylated arms
of ìgt11 and packed into Gigapack II Gold phage extracts
(Stratagene, La Jolla). The resulting phages were incubated
with E. coli strain Y1088 for 20 min at room temperature,
plated on BBL-agar, and the plates incubated at 37 °C
overnight. The resulting plaques were overlaid with SM to
elute the phages. The elutes were centrifuged and the cleared
phage-containing supernatants were adjusted to 7% DMSO.
Aliquots of the two libraries (A and B) were stored at -80
°C. The titers of the libraries were about 108 pfu/mL,
containing about 90% recombinant phages.
Cloning of C. Reinhardtii CP12. Primers were designed
from ESTs available at NCBI Genbank (AV626097 and
AV634344) (17). They were used to amplify directly CP12
(forward primer: 5′CTAGCGGCCAGCCCGCTGTG3′ and
reverse primer: 5′GAATTAGGAGCATCTGCGCCG3′) from
the C. reinhardtii cDNA library mentioned above. The PCR
product (248 bp) was cloned in pGEM-T (Promega) and
sequenced. The primers against the partial sequence of C.
reinhardtii published in ref 5 were also used (forward:
5′CCGGTTAGTGGAGAATGCG3′ and reverse: 5′GGT-
TATCCTTACAGTAATCC3′).
OVerexpression and Purification of C. reinhardtii CP12.
The N-terminal sequence of native CP12 was obtained from
C. reinhardtii purified PRK/CP12/GAPDH complex in
solution (Edman method). The N-terminal sequences of PRK
and GAPDH are known to be DKDKT and EKKIR,
respectively. The remaining amino acid residues were thus
attributed to CP12. Primers containing the NdeI and XhoI
restriction sites were used to amplify and clone mature CP12
cDNA in frame with the N-terminal histidine tag of the
pET16b expression vector (Novagen) (forward primer
5′CATATGAGCGGCCAGCCCG3′ and reverse primer
5′GAGCTCAATTAGGAGCAT CTGC3′). A cleavage site
by factor Xa is present between the histidine tag and mature
CP12.
C. reinhardtii CP12 cDNA was expressed in freshly
transformed E. coli BL21(DE3)pLysS. Bacteria were grown
in 2YT medium with 100 íg/mL ampicillin and 34 íg/mL
chloramphenicol at 37 °C until the OD600 was 0.5 to 0.6.
Cultures were cooled on ice and CP12 synthesis was induced
with 1 mM isopropyl-â,D-thiogalactopyranoside (IPTG).
Protein synthesis took place at 30 °C overnight.
Bacteria were collected by centrifugation and suspended
in Ni-NTA buffer (50 mM NaH2PO4, 300 mM NaCl, and
10 mM imidazol, pH 8.0). Cells were broken by sonication
and centrifuged at 27 000g for 20 min. The supernatant
contained recombinant CP12 bearing a histidine tag (His-
CP12). Recombinant His-CP12 was purified by metal ion
affinity chromatography on Ni-NTA agarose (Qiagen) (1.2
 8 cm). The column was equilibrated in Ni-NTA buffer.
Contaminants were first eluted out with 100 mM imidazol.
Apparently homogeneous His-CP12 was eluted with 200 mM
imidazol and stored at -20 °C.
The His-CP12 used for in vitro complex reconstitution was
digested with factor Xa (Novagen) (1u for 33 íg of CP12).
The sample was applied to a gel filtration Sephadex G50 (1
 50 cm) column in 50 mM NaH2PO4, 50 mM NaCl, pH
7.5 to separate CP12 from factor Xa and the histidine tag.
Purified CP12 was stored at -20 °C.
The PRK/CP12/GAPDH complex was purified from C.
reinhardtii WM3- as in ref 11. PRK and GAPDH may also
be purified separately to obtain the native isolated enzymes
(11). Recombinant GAPDH was purified as in ref 13.
Redox State of CP12. The free SH groups in CP12 were
quantified by alkylation of the reactive cysteine residues with
iodoacetamide. Iodoacetamide was prepared as in ref 18.
Oxidized and reduced CP12 were alkylated with 100 mM
iodoacetamide for 30 min at room temperature and in the
dark. Samples were desalted on a Zip-tip C18 and analyzed
by mass spectrometry (MALDI-TOF). Alkylation of one
cysteine residue increased the mass by 57.27 Da. Reduced
CP12 was obtained by incubating the protein with 30 mM
DTT for 1 h at 30 °C.
In Vitro Complex Reconstitution. Recombinant GAPDH
and native PRK were dialyzed separately against reconstitu-
tion buffer (30 mM Tris, 100 mM NaCl, 2 mM EDTA, 0.1
mM NAD, pH 7.9) supplemented with 5 mM Cys or 1 mM
DTT on a YM30 centricon (Amicon, Millipore). Oxidized
or reduced CP12 was added in a molar ratio of 1 monomer
of CP12 to 1 tetramer of GAPDH and 1 dimer of PRK (1:
1:1) to reconstitute the complex. The proteins were dialyzed
again in the same buffer and concentrated to 50 íL on a
YM10 centricon (Amicon - Millipore). 10% glycerol was
added and the proteins were incubated for 1 h at 30 °C and
kept at 4 °C overnight or longer.
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Surface Plasmon Resonance (SPR) Binding Experiments.
Oxidized CP12 or His-CP12 (ligand) was immobilized on
CM5 sensor chips in HBS-EP buffer (10 mM Hepes, 150
mM NaCl, 3.4 mM EDTA, 0.005% (v/v) P20, pH 7.4;
BIAcore) by amine coupling using the amine coupling kit
supplied by BIAcore. The aim of 50 RU (resonance unit)
was reached. 785 RU of reduced PRK were immobilized on
a CM5 chip by SH coupling.
A range of protein (analyte) concentrations were dialyzed
against buffer HBS-EP and 0.1 mM NAD and used to
determine the dissociation constants with a BIACORE 2000
instrument. In each interaction run, the analyte was injected
for 3 min to record the association phase to the flow cells,
after which buffer was injected for 3 min to record the
dissociation phase. The association and dissociation phases
were used to derive the dissociation and association rates
(kd and ka, respectively). The equilibrium-dissociating con-
stant (Kd) is given by Kd ) kd/ka. Global fittings of the
exponential curves (sensorgrams) giving both ka and kd values
and the response at equilibrium (Req) in RU were performed
using the BIAeval 3.1 program using a model equivalent to
the 1:1 Langmuir model for adsorption to a surface.
Circular Dichroism Studies on His-CP12. Spectra were
recorded on a Jasco-810 dicrograph and analyzed with the
programs Dicroprot (http://dicroprot-pbil.ibcp.fr/) and CDPro
(http://lamar.colostate.edu/sreeram/CDPro/main.html). All
CD spectra are averages of four accumulations from 260 to
180 nm with a scan speed of 10 nm/min. His-CP12 was
dialyzed against phosphate buffer (10 mM Na2HPO4-NaH2-
PO4, pH 6.0). Measurements were performed in 0.2 cm
quartz cuvettes in a final volume of 300 íL.
NMR Studies of His-CP12. Homonuclear NMR experi-
ments were recorded on His-tagged CP12 and CP12 in 50
mM NaH2PO4, 50 mM NaCl, pH 6.0, 10% (v/v) 2H2O. NMR
heteronuclear studies were carried out on His-CP12 synthe-
sized in M9 minimal medium containing 1 g/L of [15N]-
ammonium chloride (Isotec) as the sole nitrogen source. The
protein was purified on Ni-NTA agarose. The samples were
dialyzed against NMR buffer (50 mM NaH2PO4, 50 mM
NaCl, pH 6.0) and concentrated to 0.9 mM in a final volume
of 450 íL. A 50 íL aliquot of 2H2O (10% v/v) was added
and the sample was degassed with argon before recording.
2D homonuclear TOCSY spectra, NOESY spectra, 2D 1H-
15N HSQC spectra (19), and heteronuclear nOe {1H}-15N
spectra (20) were recorded at 27 °C on Varian Inova 400
and 600 MHz spectrometers equipped with a triple-resonance
(1H, 13C, 15N) probe, including shielded z-gradients. Spectra
were processed using FELIX version 97.0 (Accelrys).
Chemical shifts were measured with reference to the H2O
signal taken at 27 °C relative to DSS. 15N chemical shifts
used the 1H/X frequency ratios as indirect references, as
reported in ref 21.
Mass Spectrometry Studies. MALDI-TOF mass spectra
were obtained on a Voyager DE Pro mass spectrometer
(Applied Biosystems). Samples were prepared as in ref 13.
Miscellaneous Procedures. Antibodies raised against
recombinant CP12 and GAPDH from C. reinhardtii were
obtained after rabbits were given three injections of the
purified proteins. Protein concentrations were determined
with the Bio-Rad protein dye reagent, using bovine serum
albumin as standard. Native gels were performed on a Phast
System apparatus, with 4-15% gradient gels (Pharmacia).
Proteins were transferred and revealed using GAPDH, CP12,
or PRK antibodies.
RESULTS
C. Reinhardtii CP12 is Similar to Higher Plant CP12. PCR
on the cDNA library constructed from C. reinhardtii cw15
strain gave a sequence identical to that of the EST AV634344.
Genomic DNA from the WM3- strain of C. reinhardtii could
only be amplified with the primers corresponding to the
sequence of the EST. N-terminal sequencing of CP12 within
the PRK/CP12/GAPDH complex showed that the first amino
acid residues of mature CP12 embedded in the complex were
SGQPA. This sequence is identical to part of one translation
frame of our PCR product. C. reinhardtii CP12 is highly
homologous to other CP12s (Figure 1).
Recombinant CP12 is Mainly Oxidized and Contains two
Disulfide Bridges. Mass spectrometry of purified recombinant
CP12 with free thiol groups alkylated by iodoacetamide,
showed a main peak at m/z 8743, corresponding to the
unalkylated form of CP12. Given the small size of iodoacet-
amide, the absence of alkylation may be linked to the
presence of two disulfide bridges. There were also two very
weak peaks at m/z 8800 and 8856, corresponding to partially
reduced forms (data not shown).
CP12 was reduced with 30 mM DTT at 30 °C for 1 h and
the four thiol groups were alkylated by iodoacetamide. Thus,
all thiol groups were accessible after reduction (data not
shown).
Role of CP12 as a Protein-Linker in the Assembly of the
PRK/CP12/GAPDH Complex. CP12 has been isolated from
a few eukaryotic and prokaryotic photosynthetic organisms
as part of multi-enzyme complexes and the function of this
small protein in complex assembly is unknown.
The complex can be reconstituted in vitro using native
isolated PRK and GAPDH (purified from the green alga).
This reconstituted complex had the same kinetic properties
as the native one purified from C. reinhardtii (11). Yet, no
complex could ever be reconstituted in vitro using isolated
native PRK and recombinant GAPDH. The main difference
was the replacement of native isolated GAPDH, which is in
fact a complex of GAPDH and CP12, by recombinant
GAPDH (devoid of CP12). Reconstitution assays were
performed with native isolated PRK, recombinant GAPDH,
and recombinant oxidized CP12. The addition of the small
protein ensured the assembly of the complex (Figure 2).
Thus, CP12 acts as a linker that is essential for complex
assembly.
CP12 may also be obtained under a reduced state after
treatment with a strong reducing agent such as DTT. We
therefore checked whether reduced CP12 could still recon-
stitute the complex in vitro. Native PRK, recombinant
GAPDH, and reduced CP12 were concentrated together and
the complex reconstituted in the presence of 5 mM Cys
(Figure 2), but not in the presence of 1 mM DTT. Two
possibilities arose. The simplest was that reduced CP12 could
be reoxidized prior to complex assembly when the mild
reducing agent was used, but not in the presence of a stronger
reducing agent such as DTT. The other possibility was that
reduced CP12 could reconstitute the complex with formation
of its disulfide bridges at the contact of either GAPDH or
PRK in the presence of Cys. This would be prevented by
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DTT because of its higher reducing power. To test these
possibilities, we incubated reduced CP12 with the reconstitu-
tion buffer supplemented with 5 mM Cys or 1 mM DTT
overnight and alkylated CP12. 5 mM Cys did not prevent
the formation of the two disulfide bridges (no alkylation),
whereas in the presence of 1 mM DTT the four thiol groups
were alkylated (data not shown).
Influence of CP12 on the Affinity of GAPDH for PRK.
SPR studies with immobilized reduced PRK (ligand), and
different concentrations of native GAPDH (GAPDH/CP12)
(analyte) have shown that the dissociation constant (Kd) of
the native GAPDH/PRK association is 62 nM (22). We
determined the dissociation constants of different subcom-
plexes by SPR to find how oxidized CP12 acts in complex
assembly. The Kd was higher (190 nM) when recombinant
GAPDH (devoid of CP12) was used as analyte on im-
mobilized PRK (ligand) than when native GAPDH was
associated with PRK (Figure 3A).
The Kd was extremely low (0.44 nM) when oxidized His-
CP12 was used as ligand and recombinant GAPDH as
analyte (Figure 3B). The curves were fitted to a pseudo 1:1
Langmuir model. The estimated Kd was much higher when
PRK was used as analyte (1.3 íM) (Figure 3C). Repetition
of the experiments with oxidized CP12 showed that the tag
did not affect the specificity of interaction.
Wedel et al proposed a model in which the formation of
the complex involved the dimerization of two monomers of
CP12 (6). We tested this hypothesis by measuring the Kd of
oxidized CP12 on itself. The value obtained was high (51
íM). The values obtained for the Kds are summarized in
Table 1.
Structural Transitions of CP12 upon Reduction. To
determine whether the specific role of oxidized CP12 in
complex assembly, compared to reduced CP12, could be
linked to structural transitions and not only to the presence
of free thiol groups, we investigated the structure in solution
of oxidized and reduced His-CP12 by CD and NMR.
CD spectra for oxidized CP12 showed two minima, at 222
and 205 nm, indicating helical structures (Figure 4). Yet,
the maximum at 192 nm was smaller than expected for an
all R-helix protein, probably because of the presence of
random coils (minimum at 198 nm). The estimation of
protein secondary structure indicated that CP12 is composed
of R-helix with some random coil. Recombinant reduced
CP12 was also analyzed by CD and NMR to determine the
effect of reducing the two disulfide bridges on the structure
of the protein. The CD spectra showed that CP12 underwent
a dramatic conformational change after reduction and became
even more disordered. The R-helix content decreased, while
those of random coils and undetermined structures increased
(Figure 4).
FIGURE 1: Sequence of C. reinhardtii CP12 aligned with those of CP12s from other photosynthetic organisms and hypothetical sequences.
Alignment was performed with ClustalW. Hypothetical sequences were obtained by BlastP with C. reinhardtii sequence as template. Arabi1,
2, and 3: Arabidopsis thaliana putative CP12s AAL32917, NP_191800, AAM62589, respectively; Pisum: Pisum satiVum; Spina: Spinacia
oleracea; Nicot: Nicotiana tabacum; Chlamy: Chlamydomonas reinhardtii; Nosto1 and 2: Nostoc punctiforme (ZP_00106092) and Nostoc
sp. (NP_484948) (8), respectively; Synec: Synechocystis PCC6803; Thermo: Thermosynechococcus elongatus BP-1 (NP_682610) (7);
Tricho: Trichodesmium erythraeum IMS101 (ZP_00071116). All accession numbers are from NCBI.
FIGURE 2: In vitro reconstitution assays with oxidized and reduced
CP12. Proteins were transferred to a nitrocellulose membrane and
revealed with antibodies raised against PRK. Lane 1: complex
purified from C. reinhardtii (control; 2.4 íg). Lane 2: in vitro
reconstitution using native isolated PRK and recombinant GAPDH
in a molar ratio of one dimer of PRK for one tetramer of GAPDH
with 0.15 nmol of each (2 íg). Lane 3: CP12 was added to the
reconstitution mixture at a molar ratio of one monomer of CP12
for one dimer of PRK and one tetramer of GAPDH, using 0.15
nmol of each (2 íg). Lane 4: Complex reconstitution assay with
5 mM Cys using reduced CP12, in the same molar ratio with 0.06
nmol of each (0.5 íg).
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To gain further insight into the structural transition of CP12
upon reduction and the mobility of reduced CP12, we also
examined the effects of reduction by NMR. Figure 5 shows
the HSQC spectrum of an oxidized sample of 15N-CP12.
Most of the resonances are localized in the range 8.5-8 ppm.
The resonances of CP12 have not been assigned due to the
superimposition of these signals and the absence of any nOe
transfer in homonuclear NOESY experiments (data not
shown). However, a first general conclusion on CP12
properties could be drawn from the spectra. Only about a
third of the residues exhibit chemical shifts which are far
from the random coil values (Figure 5), suggesting that CP12
is only partially structured. These features, together with the
absence of nOe transfer strongly suggest that CP12 exhibits
highly dynamic properties. This is further corroborated by
1H-15N nOe experiments which show only very weak positive
heteronuclear nOe effects indicative of high mobility (data
not shown).
The reduction of oxidized CP12 caused a very large
change in the NMR spectrum. All the correlations in the
HSQC having chemical shift values different from those of
a random coil disappeared, and all the chemical shift values
of the correlations were those for a typical unstructured
peptide (Figure 5). In addition, all the heteronuclear nOe
effects became very negative, indicating that reduced CP12
was much more mobile than the oxidized form. Thus, CP12
became completely unstructured upon reduction, in agree-
ment with the CD experiments.
DISCUSSION
CP12 Is a ConserVed Protein InVolVed in Complex
Assembly. We have cloned the full sequence of CP12 cDNA
FIGURE 3: SPR binding experiments. The response at equilibrium
Req (in resonance unit (RU)) was reported as a function of the
analyte concentration. The experimental points were fitted to a
hyperbola: Req ) (Rmax[GAPDH])/(Kd + [GAPDH]). Scatchard
plots (Req/[GAPDH] versus Req) were also used and the slope gave
the same estimations (data not shown). (A) PRK was used as a
ligand and native GAPDH (O) or recombinant GAPDH (b) were
used as analyte. (B and C) Oxidized His-CP12 was immobilized
(ligand) and recombinant GAPDH (B) or native PRK (C) were used
as analyte. The errors on the estimated parameters were less than
10% in all cases.
Table 1: Dissociation Constants Obtained by Surface Plasmon
Resonance in Bold, the Lowest Kds Obtained
analyte CP12ox (M) PRK (M)
CP12ox 0.51  10-4 nd
GAPDHrec. 0.44  10-9 0.19  10-6
PRK 0.13  10-5 nd
GAPDHnat. nd 0.62  10-7
FIGURE 4: CD studies showing the structural changes of His-CP12
upon reduction. Spectra were obtained with 8 íM of oxidized His-
CP12 (black line) or reduced His-CP12 (grey line) in phosphate
buffer pH 6.0.
FIGURE 5: 15N-HSQC spectra of the oxidized and reduced form of
C. reinhardtii His-CP12. In black: HSQC spectrum at 400 MHz
of oxidized His-CP12 (0.9 mM) at 27 °C in 50 mM NaCl, 50 mM
phosphate buffer, pH 6.0; four transients by t1 increment. In red:
HSQC spectrum at 400 MHz of reduced CP12 (0.3 mM) at 27 °C
in 50 mM NaCl, 50 mM phosphate buffer pH 6.0, 10 mM DTT;
16 transients by t1 increment.
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from the unicellular green alga C. reinhardtii. It is highly
homologous to previously sequenced CP12s from higher
plants and the cyanobacterium Synechocystis PCC6803 (4-
6) (Figure 1). All CP12s cloned to date have four cysteine
residues which form two intramolecular disulfide bridges,
one between cysteines 1 and 2 and the other between
cysteines 3 and 4 (6). We confirmed the presence of these
residues in C. reinhardtii CP12, in particular cysteines 1 and
4, which had not been observed in the partial sequence
previously obtained (5). Sequence alignment shows major
differences between higher plant CP12s, cyanobacterial
hypothetical and C. reinhardtii sequences. First, the presence
of a proline residue between each pair of cysteines in higher
plant CP12s is probably responsible for the formation of two
loops in oxidized CP12 (4, 6). The prokaryotic and algal
CP12s lack the proline residue between cysteines 1 and 2,
although the proline residue between Cys 3 and 4 is present
in the CP12 of all organisms. Second, the CP12s of higher
plants have a set of compensating charged residues at their
N-terminus that may enable the protein to form dimers by
electrostatic interactions (6). The hypothetical sequences of
cyanobacteria lack the charged residues responsible for the
dimerization of CP12. This “motif” may be present in C.
reinhardtii CP12, but the amino acid residues putatively
involved are different from those of higher plants. The most
conserved part is a region of 10 residues between cysteines
2 and 3 (Figure 1), suggesting that this region may play
another, yet undefined, functional role. This study is currently
under investigation.
We investigated the role of CP12 in the assembly pathway
of the PRK/CP12/GAPDH complex. Our in vitro reconstitu-
tion assays show that oxidized CP12, in addition to modify-
ing GAPDH kinetic properties and probably conformation
(13), also acts as a linker in the assembly of the PRK/CP12/
GAPDH complex. The formation of this complex may be a
prerequisite for light-activation of the enzymes and subse-
quent docking of the other enzymes of the Benson-Calvin
cycle as higher supramolecular complexes have been de-
scribed (23-26). Complex reconstitutions with reduced CP12
were possible in the presence of 5 mM Cys, but not 1 mM
DTT (data not shown). In the presence of the weak reducing
agent (5 mM Cys), the disulfide bridges form again prior to
complex reconstitution. These results corroborate those
obtained by Wedel et al, who showed that CP12 mutants in
which Cys 1 and/or 4 were mutated into Ser failed to
reconstitute the complex (6). They confirm that the presence
of disulfide bridges is essential for complex reconstitution.
Furthermore, alkylation of the native complex shows that
CP12 within this complex is present under an oxidized form
(data not shown).
We have performed SPR binding experiments to gain
further insight into the action of CP12 and into the assembly
pathway of the PRK/CP12/GAPDH complex. We have tested
different combinations using two partners, one ligand and
one analyte, to determine which couple of partners had the
lowest dissociation constant or the highest affinity. When
CP12 was used, these studies also enabled us to determine
the role of CP12 in the assembly of the complex. On the
basis of the following data from SPR binding experiments,
in vitro reconstitution assays and the result of purifying native
enzymes, we propose a model for the assembly of the PRK/
CP12/GAPDH complex and the role of CP12:
(i) CP12 does not co-purify with PRK when the native
enzyme is isolated. The notion of a weak interaction between
PRK and CP12 is also supported by the high value of the
Kd for the interaction of PRK with oxidized CP12 (1.3 íM).
Thus, PRK does not seem to interact with CP12 to form a
stable PRK/CP12 complex.
(ii) On the contrary, native isolated GAPDH co-purifies
with CP12 and forms a very stable GAPDH/CP12 complex.
We have previously shown that the association of CP12 with
recombinant GAPDH changes the kinetic properties of the
enzyme (13). The Kd for the interaction of oxidized CP12
and GAPDH is extremely low (0.44 nM). Furthermore, in
vitro reconstitution assays using recombinant GAPDH and
PRK, but no CP12, show that these two enzymes do not
form a stable complex. The Kd for the interaction of
recombinant GAPDH (devoid of CP12) with PRK is very
high (0.19 íM) compared to the one obtained for the
interaction of the GAPDH/CP12 (native GAPDH) complex
with PRK (62 nM). These results show that the GAPDH
that is bound to CP12 and has undergone a conformation
change has more affinity for PRK than does GAPDH alone.
Thus, the first step in the assembly of the complex is the
association of CP12 with GAPDH and the subsequent change
of the conformation of the enzyme. This GAPDH/CP12
complex then becomes associated with PRK to form a half-
complex (Figure 6), defined as one unit. This unit must then
dimerize to give the native complex composed of two dimers
of PRK, two tetramers of GAPDH and, probably, two
monomers of CP12. The stoichiometry was determined by
immunoblots (data not shown). Wedel et al proposed that
dimerization involves electrostatic interactions between
negatively and positively charged residues of the N-terminal
of CP12 (6). The Kd for the dimerization of oxidized CP12
by SPR is high (51 íM). Yet, CP12 probably undergoes an
poorly structured to structured transition upon association
with GAPDH and PRK and the Kd for the dimerization of
FIGURE 6: Model describing the assembly of PRK/CP12/GAPDH
complex of C. reinhardtii. (1) GAPDH has a much higher affinity
for CP12 than for PRK and thus associates with the small protein
to form a very stable complex. (2) Binding of CP12 to GAPDH
causes the conformation of GAPDH to change (13). According to
Wedel et al (6), CP12 binds to GAPDH through its C-terminus.
(3) GAPDH acquires a higher affinity for PRK and forms a
subcomplex composed of one dimer of PRK, one tetramer of
GADPH and one monomer of CP12. As described by Wedel et al
(6), we assume that PRK interacts with the GAPDH/CP12 complex
via the N-terminus of CP12. (4) The final complex may finally be
obtained by dimerization. The interactions involve CP12/CP12
contacts and additional enzyme/enzyme interactions.
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CP12 could change. However, prokayotic CP12s do not have
such oppositely charged amino acid residues, and given the
small size of CP12 we propose that the dimerization of the
complex involves both contacts between the two enzymes
and the two CP12s of each unit (Figure 6).
Redox States and Structural Transitions of CP12. We have
shown that reduced CP12 was not able to reconstitute the
complex. To link these results with a possible structural
transition of CP12 upon reduction, we have analyzed the
conformations of CP12 in solution by CD and NMR. The
CD spectra show that oxidized CP12 has a secondary
structure, mainly composed of R helices plus some random
coils. The NMR experiments, however, indicate that CP12
does not adopt a rigid 3D structure in solution. The
heteronuclear nOe experiments on His-CP12 indicate that
the secondary structures are mobile one respect to another
in solution. Thus, even if CP12 has secondary structures,
their relative mobility makes the resolution of its 3D structure
most unlikely and the NMR datasets obtained preclude the
construction of a model. Since recombinant CP12 had two
disulfide bridges, we reduced the protein with DTT and
studied the effect of reduction on the structure of CP12. The
structure of His-CP12 changes dramatically upon reduction;
it loses almost all its R-helices and becomes highly disor-
ganized, almost unfolded and much more flexible and mobile
than oxidized CP12. These results show that flexible oxidized
CP12 may act as a linker in complex formation, whereas
reduced and unstructured CP12 loses its capacity to form
the complex. Such structural transitions with loss of function
are also observed with small proteins, such as prion proteins.
Upon transition from the normal form to the scrapie
(infectious) form, the prion protein undergoes a structural
transition from R-helical to â-sheet structures, as shown by
CD and FTIR experiments (27).
The lack of overall organization and the great flexibility
of oxidized CP12 observed by NMR and CD are in good
agreement with the role of this protein as linker. The
flexibility and the net negative charges of CP12 may increase
its reactive area and its “stickiness”, compared to rigid
partners. It thus facilitates specific interactions and increases
the rates of specific macromolecular interactions (28, 29).
Such behavior resembles that of “intrinsically unstructured
proteins” or “IUPs” (30-32). These proteins are often
involved in protein-protein interactions and play major roles
in cellular functions, such as DNA and RNA binding,
transcriptional regulation, signal transduction, and cell cycle
regulation (30). They are found in a wide variety of
macromolecular complexes: Nup2p and the nuclear pore
complex (33), Securin and cyclin B (34), complexins and
SNARE complexes (35-37), IF1 and the regulation of
ATPases (38-40), p21 or p27kip1 and regulation of CDK2,
cyclin A or PCNA (41, 42). Like CP12, their flexibility
favors the binding of several partners and the possibility of
presenting larger interaction surfaces, compared to rigid
partners. A recent survey of several genomes indicated that
34% of all proteins have at least one disordered segment
(32). CP12 proteins thus appear as one of the few known
IUPs specific to plants, in addition to Dsp16, a dehydrin-
related protein, involved in the response to abiotic stresses
such as drought, low temperature, and salinity (43), and a
manganese-stabilizing protein (MSP) of 33 kDa which is part
of photosystem II (44).
Interestingly, IUPs display residual secondary structures
and hence are not true random-coil proteins (29). It has been
speculated that these residual structures would be the same
as those observed in the complex (31). CP12 probably has
the same behavior and should become structured upon
association with the other proteins of the complex. NMR
techniques are now accurate enough to study the structure
of a small [15N] labeled protein that forms part of a
macromolecular complex (45). This matter is currently under
investigation.
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